Moving from retatrutide to a moderate dose of semaglutide or tirzepatide can provide ongoing appetite suppression at a lower cost point
If you experience any adverse effects, stop use and consult your healthcare provider.*
Therefore, a clinic should not describe compounded tirzepatide as a generic version of an FDA-approved drug
Lactation Transfer Risk: What We Know About GLP-1 Compounds in Breast Milk GLP-1 receptor agonists are large peptide molecules with poor oral bioavailability, suggesting minimal infant absorption if present in breast milk
Nutrients 9 , 1267 (2017)
When combined with certain high-fat, high-sugar, or heavily processed foods, this mechanism can trigger nausea, vomiting, and digestive discomfort